VUGENE specializes in bioinformatics and multi-omics data analysis for biomedical research and innovative therapeutics.
VUGENE has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in May 2025.
VUGENE's investors include Superhero Capital, Coinvest Capital, NGL.
VUGENE is headquartered in Vilnius, Lithuania.
VUGENE specializes in bioinformatics and multi-omics data analysis for biomedical research and innovative therapeutics.
VUGENE is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VUGENE — Funding & Investors." VCBacked, May 5, 2025, https://www.vcbacked.co/company/vugene. Accessed September 30, 2026.
VCBacked. (2025). VUGENE — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/vugene
{{cite web |title=VUGENE — Funding & Investors |url=https://www.vcbacked.co/company/vugene |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated